Negative regulation of eosinophil recruitment to the lung by the chemokine monokine induced by IFN-gamma (Mig, CXCL9)

Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1987-92. doi: 10.1073/pnas.0308544100. Epub 2004 Feb 9.

Abstract

Experimental analysis of allergic airway inflammation (AAI) in animals and humans is associated with coordinate gene induction. Using DNA microarray analysis, we have identified a large panel of AAI signature genes. Unexpectedly, the allergen-challenged lung (a T helper 2 microenvironment) was found to be associated with the expression of T helper 1-associated CXCR3 ligands, monokine induced by IFN-gamma (Mig), and IFN-gamma-inducible protein of 10 kDa (IP-10). Here we report that Mig functions as a negative regulator of murine eosinophils. Whereas Mig was not able to induce chemotaxis of eosinophils, pretreatment with Mig induced a dose-dependent inhibition of chemoattractant-induced eosinophil transmigration in vitro. Moreover, i.v. administration of low doses of Mig ( approximately 10-30 microg/kg) induced strong and specific dose-dependent inhibition of chemokine-, IL-13-, and allergen-induced eosinophil recruitment and, conversely, neutralization of Mig before allergen challenge increased airway eosinophilia. Importantly, Mig also inhibited a CCR3-mediated functional response in eosinophils. These results indicate that the ultimate distribution and function of inflammatory cells within the allergic lung is dictated by a balance between positively and negatively regulatory chemokines. The identification of a naturally occurring eosinophil inhibitory chemokine pathway in vivo provides a strategic basis for future therapeutic consideration.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Allergens / immunology
  • Animals
  • Chemokine CCL11
  • Chemokine CXCL9
  • Chemokines, CC / antagonists & inhibitors
  • Chemokines, CC / pharmacology
  • Chemokines, CXC / genetics
  • Chemokines, CXC / pharmacology*
  • Chemotaxis, Leukocyte / drug effects*
  • Endocytosis / drug effects
  • Eosinophils / cytology*
  • Eosinophils / drug effects*
  • Female
  • Gene Expression Regulation
  • Intercellular Signaling Peptides and Proteins / genetics
  • Intercellular Signaling Peptides and Proteins / pharmacology*
  • Interleukin-13 / antagonists & inhibitors
  • Interleukin-13 / pharmacology
  • Ligands
  • Lung / cytology*
  • Lung / drug effects
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Transgenic
  • Ovalbumin / antagonists & inhibitors
  • Ovalbumin / immunology
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Receptors, CCR3
  • Receptors, CXCR3
  • Receptors, Chemokine / metabolism
  • STAT6 Transcription Factor
  • Trans-Activators / deficiency
  • Trans-Activators / genetics
  • Trans-Activators / metabolism
  • Transcriptional Activation

Substances

  • Allergens
  • CCL11 protein, human
  • CCR3 protein, human
  • CXCL9 protein, human
  • CXCR3 protein, human
  • Ccl11 protein, mouse
  • Ccr3 protein, mouse
  • Chemokine CCL11
  • Chemokine CXCL9
  • Chemokines, CC
  • Chemokines, CXC
  • Cxcr3 protein, mouse
  • Intercellular Signaling Peptides and Proteins
  • Interleukin-13
  • Ligands
  • RNA, Messenger
  • Receptors, CCR3
  • Receptors, CXCR3
  • Receptors, Chemokine
  • STAT6 Transcription Factor
  • Stat6 protein, mouse
  • Trans-Activators
  • Ovalbumin